Suppr超能文献

面部移植8年后的面部创伤

Facial Trauma 8 years after a Face Transplantation.

作者信息

Goutard Marion, Lellouch Alexandre G, Dussol Bertrand, Lantieri Laurent A

机构信息

Department of Plastic Reconstructive Surgery, European Georges Pompidou Hospital (AP-HP), Paris, France.

Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

出版信息

Plast Reconstr Surg Glob Open. 2021 May 21;9(5):e3575. doi: 10.1097/GOX.0000000000003575. eCollection 2021 May.

Abstract

Over the past 20 years, vascularized composite allografts (VCAs) have emerged as a realistic option in reconstructive surgery. Long-term follow-up reports indicate that face transplant patients have gained in quality of life and social integration. However, they require close monitoring of their immunosuppressive therapy because they are at high-risk for acute rejection episodes, leading eventually to chronic rejection and allograft loss. Reported acute rejection episodes in VCA recipients occur due to low immunosuppressive therapy (mainly due to lack of patient compliance or decreased doses of immunosuppressants to counter side-effects). Repeated mechanical traumas have recently been shown to trigger acute rejection episodes, especially in hand transplant patients. This article reports our experience of a 10-year follow-up of a 57-year-old face transplant patient and the management of his accidental facial trauma. To our knowledge, our patient is the first to undergo a major trauma on his VCA endangering his graft function and vitality. This report discusses the management of an acute surgical situation in those particular patients, and the challenges that arise to avoid acute rejection of the allograft. Ten years into his face transplant and at 18 months follow-up after his facial trauma, our patient shows great aesthetic and functional outcomes and remains rejection-free; a very encouraging result for all VCA candidates.

摘要

在过去20年里,血管化复合组织异体移植(VCA)已成为重建手术中的一种现实选择。长期随访报告表明,面部移植患者的生活质量和社会融入度有所提高。然而,由于他们面临急性排斥反应发作的高风险,最终可能导致慢性排斥反应和移植物丢失,因此需要密切监测其免疫抑制治疗情况。VCA受者报告的急性排斥反应发作是由于免疫抑制治疗不足(主要是由于患者依从性差或为应对副作用而减少免疫抑制剂剂量)。最近发现,反复的机械性创伤会引发急性排斥反应发作,尤其是在手部移植患者中。本文报告了我们对一名57岁面部移植患者进行10年随访以及对其意外面部创伤的处理经验。据我们所知,我们的患者是首例其VCA遭受严重创伤并危及移植物功能和活力的患者。本报告讨论了这类特殊患者急性外科情况的处理,以及为避免同种异体移植物急性排斥反应而出现的挑战。在面部移植10年后以及面部创伤后18个月的随访中,我们的患者显示出了极佳的美学和功能效果,且未发生排斥反应;这对所有VCA候选者来说都是一个非常令人鼓舞的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c46/8140768/2fba7c787823/gox-9-e3575-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验